Trials / Completed
CompletedNCT04651179
Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma
A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna · Academic / Other
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
A retrospective observational study of the effectiveness of gemcitabine - docetaxel in patients with relapsed osteosarcoma who have been treated with HD IFO in first line treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation | not applicable, observational study |
Timeline
- Start date
- 2020-04-24
- Primary completion
- 2021-06-06
- Completion
- 2021-11-23
- First posted
- 2020-12-03
- Last updated
- 2021-11-26
Locations
8 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT04651179. Inclusion in this directory is not an endorsement.